M6a methylation regulators are predictive biomarkers for tumour metastasis in prostate cancer

HIGHLIGHTS

  • who: Yingchun Liang and collaborators from the Department of Urology, Huashan Hospital, Fudan University, No, WuLuMuQi Middle Road, Shanghai, China have published the research: m6A Methylation Regulators Are Predictive Biomarkers for Tumour Metastasis in Prostate Cancer, in the Journal: Cancers 2022, x of 27/07/2022
  • what: The authors demonstrated that the subtypes of PCa according to the clustering of m6 A regulators of expression are significantly associated with PCa metastasis.
  • how: The overall survival (OS) and recurrence-free survival (RFS) of each m6 A subtype were compared to investigate the correlation of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?